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Abstract
Background: Incidence of type 1 diabetes mellitus is increasing worldwide. Monitoring glycaemia is essential for
control of diabetes mellitus. Conventional blood-based measurement of glucose requires venepuncture or needle
prick, which is not free from pain and risk of infection. The non-invasiveness, ease and low-cost in collection made
saliva an attractive alternative sample. The objective of this review was to systematically review the evidence on the
relationship between salivary glucose level and blood glucose level in monitoring glycaemia in patients with type 1
diabetes mellitus.
Methods: We searched studies which evaluate salivary glucose levels and serum glycaemia in type 1 diabetes
mellitus in electronic databases of MEDLINE, EMBASE, Ovid and Google Scholar. We selected the eligible studies,
following the inclusion criteria set for this review. Due to heterogeneity of studies, we conducted qualitative
synthesis of studies.
Results: Ten observational studies were included in this review, including a total of 321 cases and 323 controls
with ages between 3 and 61 years and the majority were males (62%). Two studies were done exclusively on
children below 17 years old. The significant difference between salivary glucose levels in type 1 diabetes mellitus
and controls were reported in 6 studies with 8 data sets. Five studies with 7 datasets reported the correlation
coefficient between salivary glucose and blood glucose in patients with diabetes.
Conclusions: Findings suggest that salivary glucose concentrations may be helpful in monitoring glycaemia in type
1 diabetes mellitus. However, the utility of using salivary glucose level to monitor glycaemia should be evaluated in
future well designed, prospective studies with adequate number of participants with type 1 diabetes mellitus.
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Background
Diabetes mellitus, a group of metabolic diseases character-
ized by chronic hyperglycaemia resulting from defects in
insulin secretion, insulin action, or both can be broadly
categorized into type 1 diabetes mellitus (destruction of
pancreatic beta cells, causing absolute deficiency of
insulin), type 2 diabetes mellitus (a combination of
decreased insulin secretion and decreased insulin sensitiv-
ity (i.e. insulin resistance) [1], gestational diabetes mellitus
[2], other specific types of diabetes mellitus — monogenic
diabetes mellitus/maturity onset diabetes of the young,
genetic defects of beta-cell function or insulin action,
diseases of pancreas, drug induced or associated with
genetic syndromes and others (i.e. monogenic mutation in
chromosome 12 or 7p, mitochondrial DNA, cystic fibrosis,
hemochromatosis, endocrinopathies etc.) [1]. The inci-
dence of type 1 diabetes mellitus is increasing worldwide
both in low and high income populations [3]. Type 1
diabetes mellitus can affect people of any age, but usually
occurs in children or young adults [1], the age group
whose learning and earning potentials and capacities are
crucial for the welfare of family and society at large.
Studies have documented that normalization of blood
glucose levels can result in regression of diabetes associ-
ated complications such as peripheral neuropathy and
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peripheral vascular disease [4]. Repeated monitoring of
plasma glucose in people with diabetes mellitus helps
with timely identification of hyperglycaemia and is
crucial for prevention of such devastating complications
that can arise from poor control of the disease. The
conventional method of blood-based investigations
involve invasive procedures for blood sample collections
from patients. This could evoke needle anxiety or a risk
of blood-borne infections or both. Studies have shown
that prevalence of needle anxiety in paediatric patients
was 27% [5] and 22% of all patients of all ages in general
practices [6]. Fear of sharp objects (needle) could further
discourage some patients from monitoring their blood
sugar levels regularly. It has been documented that
20.5% of those who reported needle anxiety avoided
medical treatment involving needles [6].
Published studies have indicated the possible utility of sal-
iva in monitoring of uric acid for cardiometabolic risk [7],
drugs such as theophylline and steroids, quantitation of
viral nucleic acids in herpes simplex virus DNA, varicella
zoster virus DNA, and hepatitis C virus RNA [8], identifica-
tion of biomarkers (IL-1β, -6, -8, TNF-α, lysozyme, MMP-
8, TIMP-1) and total protein concentration in systemic
diseases [9], inter alia. The non-invasiveness, ease and low-
cost in collection have made saliva an attractive sample.
There has been a surge in published studies on the
usefulness of saliva for monitoring of glycaemia. Some
studies showed that salivary glucose levels were high in
type 1 diabetes mellitus compared to controls [10] or
were positively related to serum glucose in patients with
diabetes, albeit with variation in the magnitude of rela-
tionships. Some studies reported differently [11, 12]. We
are aware of the reviews looking at the usefulness of
salivary glucose to monitor glycaemia in type 2 diabetes
mellitus [13] or non-specified diabetes mellitus [14, 15].
Although all forms of diabetes mellitus are characterised
by hyperglycaemia, their aetiology and pathogenesis vary.
Acute, long-term and post-prandial hyperglycaemia are
some of the conditions associated with endothelial dys-
function in type 1 diabetes mellitus [16]. Secretory activity
of many exocrine glands (including salivary glands) de-
pend on blood flow to these glands which in turn might
depend on endothelial production of nitric oxide. Taken
together, attention to the usefulness of saliva in monitor-
ing of glycaemia in type 1 diabetes mellitus is valuable.
The objective of the current review was to systematically
review the evidence on the relationship between salivary
glucose level and blood glucose level in monitoring
glycaemia in patients with type 1 diabetes mellitus.
Methods
We conducted this systematic review, following the
guideline for the preferred reporting items of systematic
review and meta-analysis (PRISMA) [17].
Literature search
We searched studies which evaluate salivary glucose
levels and serum glycaemia in type 1 diabetes mellitus in
electronic databases of MEDLINE, EMBASE Ovid and
Google Scholar. Search terms for studies were identified
through medical subject headings (MeSH) as well as
from those used for systematic reviews in similar
context. MeSH terms and text words used were “saliva
AND glucose” “sugar AND saliva” “saliva AND gly-
caemia” “diabetes AND saliva”, “saliva AND glycaemia”,
“IDDM AND glycaemia” and “type 1 diabetes AND
glycaemia”. The search was limited to publications in
English language up to August 2016. We also manu-
ally checked the reference sections of the selected
studies and relevant reviews for the possibility of any
additional studies that might have been missed by the
electronic search.
Study selection
Studies were included if they were observational studies
(survey, cross-sectional, case-control, cohort) carried
out with minimum 10 participants of type 1 diabetes
mellitus, regardless of age, gender and pregnant state
and assessed correlation between salivary glucose con-
centration and blood sugar level in the same patient,
compared mean salivary glucose levels between those
with type 1 diabetes mellitus and healthy controls or
those without diabetes mellitus.
Studies were excluded if they did not meet the in-
clusion criteria or assess participants with other comor-
bid diseases, which can alter salivary gland functions.
Diabetes mellitus was confirmed (i) by self-report of
patients with supportive medical records, (ii) as per the
criteria by the expert committee on diagnosis and classi-
fication of diabetes mellitus [2], or (iii) by the American
Diabetes Association (ADA) standards of medical care in
diabetes [18].
Data extraction from studies
One author (CN) screened titles and abstracts identified
according to the selection criteria set for this review and
this was cross-checked by the second assessor (JWM).
The two authors then independently retrieved full-text
copies of all articles that might be potentially relevant.
The two authors then collected data from each study
using a piloted spreadsheet. Data collected were author,
year of publication, study country and setting, study
design, original purposes, sample size, saliva collection,
methods of glucose estimation and main outcome. The
methodological quality of primary studies was assessed
using the Newcastle-Ottawa Scale (NOS) [19]. The
instrument used a star system to assess the study quality
and the highest total score for a study that could be
achieved was nine. During these processes, any discrepancy
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between the two authors was resolved by reaching a
consensus by discussion.
Statistical analyses
The studies identified for the current review used differ-
ent outcome measures. As such, a variety of transforma-
tions were required to estimate the effect sizes [20, 21].
When studies reported ‘correlation coefficients’ between
salivary glucose and blood glucose levels in persons with
type 1 diabetes mellitus, we made transformation into
approximate normality based on Fisher’s z score. If the
correlation coefficient was not reported, we estimated
Fisher’s z score from the t statistic of the linear associ-
ation between salivary glucose and blood glucose. When
studies reported the mean differences (± standard devi-
ation, SD) of saliva glucose and blood glucose levels in
type 1 diabetes mellitus and controls or non- diabetes
mellitus, effect sizes for continuous measures were ap-
propriate to apply. We considered Hedge’s standardized
mean difference g as an effect size index described
elsewhere [21–23]. Due to substantial heterogeneity of
studies, we did not make the pooling of effect size
estimates [24]. Statistical analysis was done with Stata
14 (TX: StataCorp LP). We reported the current
systematic review, according to the PRISMA checklist
[25] (Additional file 1).
Results
The four-phase study selection process is presented in
Fig. 1. An initial search yielded 1708 citations. Of these,
25 studies were potentially relevant, and a final of 10
studies (with 12 data sets) [10, 12, 26–33] were included
in the current review. The agreement between two
investigators was substantial (kappa statistics 0.81).
The excluded studies were those which did not pro-
vide sufficient data on type 1 diabetes mellitus [34–36],
did not give a separate data on type 1 diabetes mellitus
[37–39], did not assess type 1 diabetes mellitus patients
[38–41] or they did assess type 1 diabetes mellitus but
not the glucose levels [42–46].
Characteristics of the included studies
The main characteristics of the included studies are
presented in Table 1. These studies included a total of
Fig. 1 Study selection process
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321 cases and 323 controls with ages between 3 and
61 years. Two studies were done exclusively on children
with 17 years and below [10, 29]. Eight studies [10, 12,
27–31, 33] gave data on gender participants and the
majority were males (62%, 158/255).
Four studies were done in India [30–33], and one
each in Argentina [10], Greece [29], Iran [12], Sweden
[28], the UK [27] and the USA [26]. Seven studies
reported information related to blood glucose assess-
ments. Four of these 7 studies (57%) obtained fasting
blood samples [30–33] and measured glucose level
with glucose oxidase-peroxidase method (GOPD) [27,
31–33]. For glucose estimations in saliva, four studies
used glucose-oxidase method (GOD) [10, 26, 30, 32],
three studies used GOPD [29, 31, 33], two studies
used enzymatic ultraviolet detection method [27, 28],
and the remaining one used kit-based GOD (Pars
Azmoon Co, Tehran, Iran). The majority of studies
(67%) collected saliva samples after at least 2 h of
fasting [10, 12, 28–30, 33].
Six studies (8 data sets) reported the significant differ-
ence between salivary glucose levels in type 1 diabetes
mellitus and controls [10, 12, 26, 29, 30, 33]. Five studies
(7 data sets) reported the correlation coefficient between
salivary glucose and blood glucose in patients with
diabetes [27, 28, 30, 31, 33]. Three studies provided mean
differences in two different groups of controls, healthy
controls and control population with type 2 diabetes mel-
litus in one study [10] and poorly controlled/uncontrolled
and well controlled/controlled diabetes mellitus in two
studies [26, 30].
In general, the methodological quality of these studies
were low due to poor quality in performance, reporting
or both. Also, these studies failed to do (adequate)
follow-up assessments for a stability of their findings.
Five of the ten included studies (50%) in this current
review could achieve 5 out of the maximum 9 stars
given [10, 26, 27, 30, 31] (Additional file 2).
Effect size
Two individual studies showed large effect size (Hedge’s
g 3.75, 95%CI: 2.9–4.59) [26] and (standardised mean
difference, Hedge’s g 4.27, 95%CI: 3.42–5.31) [33]. Due
to heterogeneity of studies in view of variation in blood
sample collection time and the saliva collection methods,
pooling of standardised mean difference represented by
Hedge’s g index was not attempted. The Harrison study
[26] collected blood glucose 1 h after fasting, while the
Shahbaz study [33] used overnight sample. Five studies
with exclusively type 1 diabetes mellitus [10, 12, 26, 29,
33] reported the mean glucoses levels in saliva and blood
and the effect size of each study in terms of Hedge g
values were varied from a small effect size (g = -0.43) in
the Vaziri study [12] to a substantially higher effect
size (g = 4.37) in the Shahbaz study [33] (Table 2).
Due to substantial heterogeneity of studies, the pool-
ing of effect size was not done. A positive as well as
large summary standard mean difference with non-
zero overlapping in some of these studies [26, 29, 33]
suggested there was some ground to believe that
salivary glucose concentrations in the type 1 diabetes
mellitus groups were higher than that in the controls.
Five studies reported the correlation between salivary
glucose and blood sugar levels in the type 1 diabetes
mellitus groups. All these studies showed statistically
significant correlations varied from weak positive (r = 0.11)
to strong positive relationships (r = 0.99) (Table 3). Due to a
substantial within study heterogeneity, it was not possible
to make pooling of studies. Almost perfect relationship be-
tween blood and salivary glucose was found in two studies;
r = 0.98 in one study [33] and r = 0.99 in another study [31].
Two studies [26, 30] provided data on those patients
with controlled (well controlled) diabetes mellitus as
well as those with uncontrolled (poorly controlled)
diabetes mellitus. The Harrison study [26] showed that
the mean salivary glucose level (mg/ml) was lower in
the healthy controls (5 ± 1) or good controlled diabetes
Table 2 Distribution of the effect size of the difference between means salivary glucose levels in type 1 diabetes and controls
Study [ref] Effect size, Hedge’s g Lower 95%CI Upper 95%CI
Shahbaz,2014 [33] 4.37 3.4 5.31
Behal, 2012 [32] 0.48 0.09 0.87
Panchbhai,2010a [30] 1.31 0.82 1.8
Panchbhai,2010b [30] 1.22 0.75 1.69
Vaziri,2010a [12] −0.03 −0.56 0.5
Vaziri,2010b [12] −0.43 −0.88 0.02
Lopez,2003 [10] 1.37 0.68 2.06
Harrison, 1987a [26] 3.37 2.59 4.15
Harrison, 1987b [26] 3.75 2.91 4.59
Belazi,1998 [29] 1.3 0.34 2.26
a:controlled or good controlled diabetes mellitus; b: uncontrolled or poorly controlled diabetes mellitus
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(11 ± 2) than the poorly controlled diabetes mellitus of
4–19 years patients (22 ± 7). The same pattern was
found in a study by Panchbhai and associates (30); the
mean salivary glucose level (mg/ml) was lower in the
healthy adults (1.9 ± 1.4) than the controlled (7.69 ± 6.4)
and uncontrolled adult diabetes mellitus (8.1 ± 6.5). As
only two studies provided these information and the age
group of participants in these studies varied, we did not
make pooling of these studies.
Discussion
Based on available data, the current meta-analysis
provides insights to the utility of saliva in monitoring
glycaemia in patients with type 1 diabetes mellitus. Find-
ings suggests that salivary glucose concentrations in the
type 1 diabetes mellitus groups were higher than in the
controls. Due to a small number of studies with poor
methodological quality and variation in reporting of
outcome measures, there was no conclusive evidence on
the usefulness of salivary glucose concentrations in
monitoring glycaemia in type 1 diabetes mellitus.
Saliva contains serumnal components transported
from blood capillaries into saliva by diffusion, active
transport, and/or ultra- filtration via gingival sulcus.
Hence, saliva can serve as a partial filtrate of blood for
monitoring the health status of a person [47]. The
rationale for the use of saliva in monitoring hypergly-
caemia could have many explanations. Glucose is a small
molecule which can easily diffuse through semiperme-
able membranes. The alteration in basement membrane
of blood vessels (in patients with diabetes mellitus) leads
to increased diffusion of glucose from blood to saliva
[33]. Thus, large amounts of glucose concentrate in sal-
iva of patients with diabetes mellitus [21, 26]. Moreover,
salivary glands act as filters of blood glucose that would
be altered by hormonal or neural regulations [10, 48]
under several conditions of stress in humans [48].
Hence, salivary glucose level decreased after beginning
insulin treatment in both children and adolescents [49],
while infections (e.g candidiasis in those with dentures
or HIV) and inflammation of salivary glands could in-
crease the glucose level in saliva [31].
The substantial heterogeneity in the current meta-
analysis could be due to a diversity in sample se-
lection criteria (stimulated vs unstimulated, fasting
hours prior to sample collection), methodological
quality of study, underlying comorbid diseases as well
as duration of diabetes mellitus and treatment status
of diabetes mellitus (poorly controlled or well con-
trolled). For instance, an individual study has shown
a higher level of salivary glucose in the poorly con-
trolled group than in the well-controlled group of
type 1 diabetes mellitus (22.0 ± 7.0 μg/ml vs 11 ±
1 μg/ml) [26]. Thus far, we are not aware of any
studies that provide sensitivity and specificity of saliv-
ary glucose levels in monitoring glycaemia in any type
of diabetes mellitus. Future studies are required along
this line of investigation.
There are some limitations in the present study.
Salivary glucose concentration on glycaemia was time-
dependent as the concentration of glucose in the
parotid saliva remains elevated at least 2 h after glu-
cose/food intake in both normal subjects and persons
with diabetes mellitus [28, 37]. Hence the time and
method of saliva collection can affect the estimated
glucose level. Comorbid conditions could not be ruled
out among the participants in the included studies.
Many of the included studies were poor in the meth-
odological quality and reliability of the findings is
questionable. We did not perform age-specific analysis
as there were large differences in the age groups of
participants in these studies. This has important
implications as the elderly groups are more likely to
have other systemic diseases. Only two of ten stud-
ies in this meta-analysis were carried out in under
16-year-old children [10, 29]. An interpretation of
our results should be aware of these potential
confounding factors.
There may be confounding factors in the included
studies such as the presence of co-morbidity, compli-
ance to effective treatment, and age difference in par-
ticipants. Inadequate data do not allow us to perform
stratified analyses based on all these influencing fac-
tors. Due to the small number of studies with the
small sample sizes, the possibility of type II statistical
error cannot be ruled out, as the selected studies
were not adequately powered to test for differences in
the outcomes.
Conclusions
Findings suggest that salivary glucose concentrations
may be helpful in monitoring glycaemia in type 1
diabetes mellitus. However, the clinical utility of
using salivary glucose level to monitor glycaemia
should be evaluated in future well designed pro-
spective studies.
Table 3 The relationship between blood and salivary glucose
levels in type 1 diabetes
Study [Ref] Sample size Correlation coefficient Z score
Andersson,1998 [28] 36 0.52 .5763397
Darwazeh, 1991 [27] 41 0.33 .3428283
Panchbhai, 2010a [30] 40 0.4 .0400214
Panchbhai, 2010b [30] 40 0.11 .1104469
Nagalaxmi, 2011 [31] 50 0.99 2.646653
Shahbaz, 2014 [33] 30 0.98 2.410142
acontrolled diabetes mellitus; buncontrolled diabetes mellitus
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